Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Small-Cap Stocks to Buy Now?

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the most shorted mid-cap and small-cap stocks to buy now. On May 8, Chardan reiterated Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) as a Buy but lowered its price target of the stock  to $14 from $16. The price target cut  is in response to Amtagvi’s launch guidance.

Is Iovance Biotherapeutics, Inc. (IOVA) One of the Most Shorted Small Cap Stocks to Buy Now?

The company delivered solid first-quarter results driven by growth in the tumor-infiltrating lymphocyte (TIL) therapy Amtagvi. The company also reiterated that it is positioned for long-term revenue growth while advancing multiple ongoing and new clinical trials.

Revenue was up 45% year over year to $71 million, driven by accelerating Amtagvi adoption and a better cost structure. For the second quarter, Iovance Biotherapeutics expects revenue of between $86 million and $88 million, ahead of the street estimate of $84.36 million. Amtagvi’s revenue is expected to be between $79 million and $81 million.

For the full year, Iovance is projecting revenue of $350 million to $370 million, compared with $359.7 million that analysts expect. The full-year guidance underscores confidence in the company’s commercialization of Amtagvi amid strong demand.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is a biopharmaceutical company pioneering Tumor-Infiltrating Lymphocyte (TIL) therapies to treat solid tumor cancers. It harnesses the patient’s own immune system by extracting, expanding, and reinfusing these naturally occurring immune cells to recognize and destroy cancer cells.

While we acknowledge the risk and potential of IOVA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than IOVA and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: Top 10 Small Cap Stocks With Huge Growth Potential and Renaissance Technologies Returns, AUM, CEO and Top 10 Semiconductor Stock Picks.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1